Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Rizzi

Showing results (121-130 of 128) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 128 results.
Allergy|March 14, 2013
Schnitzler's syndrome: diagnosis, treatment, and follow-upA Simon, B Asli, M Braun-Falco, et al.
Allergy|August 27, 2016
Schnitzler syndrome: validation and applicability of diagnostic criteria in real-life patientsL Gusdorf, B Asli, S Barbarot, et al.
Alimentary Pharmacology & Therapeutics|September 21, 2006
A randomized trial of pegylated-interferon-alpha2a plus ribavirin with or without amantadine in the re-treatment of patients with chronic hepatitis C not responding to standard interferon and ribavirinA Ciancio, A Picciotto, C Giordanino, et al.
Leukemia Research|February 1, 2015
"Real world" outcome of lenalidomide plus dexamethasone in the setting of recurrent and refractory multiple myeloma: extended follow-up of a retrospective multicenter study by the "rete ematologica pugliese"G Mele, A Melpignano, G Quarta, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 20, 2006
TLQP-21, a VGF-derived peptide, increases energy expenditure and prevents the early phase of diet-induced obesityA Bartolomucci, G La Corte, R Possenti, et al.
American Journal of Hematology|November 19, 2024
First-line treatment of Waldenström's macroglobulinemia in Italy: A multicenter real-life study on 547 patients to evaluate the long-term efficacy and tolerability of different chemoimmunotherapy strategiesFrancesco Autore, A Tedeschi, G Benevolo, et al.
ESMO Open|January 8, 2025
Outcomes and prognostic indicators in daratumumab-refractory multiple myeloma: a multicenter real-world study of elotuzumab, pomalidomide, and dexamethasone in 247 patientsE A Martino, S Palmieri, M Galli, et al.
Neuro-Oncology Practice|June 3, 2015
Pattern of care and effectiveness of treatment for glioblastoma patients in the real world: Results from a prospective population-based registry. Could survival differ in a high-volume center?Alba A Brandes, Enrico Franceschi, Mario Ermani, et al.
Pageof 13

Showing results (121-130 of 128) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 128 results.
Allergy|March 14, 2013
Schnitzler's syndrome: diagnosis, treatment, and follow-upA Simon, B Asli, M Braun-Falco, et al.
Allergy|August 27, 2016
Schnitzler syndrome: validation and applicability of diagnostic criteria in real-life patientsL Gusdorf, B Asli, S Barbarot, et al.
Alimentary Pharmacology & Therapeutics|September 21, 2006
A randomized trial of pegylated-interferon-alpha2a plus ribavirin with or without amantadine in the re-treatment of patients with chronic hepatitis C not responding to standard interferon and ribavirinA Ciancio, A Picciotto, C Giordanino, et al.
Leukemia Research|February 1, 2015
"Real world" outcome of lenalidomide plus dexamethasone in the setting of recurrent and refractory multiple myeloma: extended follow-up of a retrospective multicenter study by the "rete ematologica pugliese"G Mele, A Melpignano, G Quarta, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 20, 2006
TLQP-21, a VGF-derived peptide, increases energy expenditure and prevents the early phase of diet-induced obesityA Bartolomucci, G La Corte, R Possenti, et al.
American Journal of Hematology|November 19, 2024
First-line treatment of Waldenström's macroglobulinemia in Italy: A multicenter real-life study on 547 patients to evaluate the long-term efficacy and tolerability of different chemoimmunotherapy strategiesFrancesco Autore, A Tedeschi, G Benevolo, et al.
ESMO Open|January 8, 2025
Outcomes and prognostic indicators in daratumumab-refractory multiple myeloma: a multicenter real-world study of elotuzumab, pomalidomide, and dexamethasone in 247 patientsE A Martino, S Palmieri, M Galli, et al.
Neuro-Oncology Practice|June 3, 2015
Pattern of care and effectiveness of treatment for glioblastoma patients in the real world: Results from a prospective population-based registry. Could survival differ in a high-volume center?Alba A Brandes, Enrico Franceschi, Mario Ermani, et al.
Pageof 13